Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
2.
Benef Microbes ; 8(4): 597-604, 2017 Aug 24.
Article in English | MEDLINE | ID: mdl-28555501

ABSTRACT

In this study, we aimed to investigate some functional characteristics and the immunomodulatory properties of three strains of Lactobacillus plantarum of dairy origin which, in a previous screening, showed to be candidate probiotics. Genome sequencing and comparative genomics, which confirmed the presence of genes involved in folate and riboflavin production and in the immune response of dendritic cells (DCs), prompted us to investigate the ability of the three strains to accumulate the two vitamins and their immunomodulation properties. The ability of the three strains to release antioxidant components in milk was also investigated. Small amounts of folate and riboflavin were produced by the three strains, while they showed a good antioxidant capacity in milk with FRAP method. The immune response experiments well correlated with the presence of candidate genes influencing in DCs cytokine response to L. plantarum. Specifically, the amounts of secreted cytokins by DCs after stimulation with cells of Lp790, Lp813 and Lp998 resulted pro-inflammatory whereas stimulation with culture supernatants (postbiotics) inhibited the release of interleukin (IL)-12p70 and increased the release of the anti-inflammatory IL-10 cytokine. This study adds further evidence on the importance of L. plantarum in human health. Understanding how probiotics (or postbiotics) work in preclinical models can allow a rational choice of the different strains for clinical and/or commercial use.


Subject(s)
Dendritic Cells/drug effects , Immunologic Factors/administration & dosage , Lactobacillus plantarum/genetics , Milk/microbiology , Probiotics/administration & dosage , Animals , Cattle , Cells, Cultured , Dendritic Cells/immunology , Genome, Bacterial , Genomics , Humans , Interleukin-10/genetics , Interleukin-10/immunology , Interleukin-12/genetics , Interleukin-12/immunology , Lactobacillus plantarum/classification , Lactobacillus plantarum/immunology , Lactobacillus plantarum/isolation & purification , Phylogeny
3.
PLoS One ; 10(11): e0142815, 2015.
Article in English | MEDLINE | ID: mdl-26562315

ABSTRACT

Cancer-associated fibroblasts (CAF) play a crucial role in regulating cancer progression, yet the molecular determinant that governs the tumor regulatory role of CAF remains unknown. Using a mouse melanoma model in which exogenous melanoma cells were grafted on the skin of two lines of mice where the genetic activation or inactivation of Notch1 signaling specifically occurs in natural host stromal fibroblasts, we demonstrated that Notch1 pathway activity could determine the tumor-promoting or tumor-suppressing phenotype in CAF. CAF carrying elevated Notch1 activity significantly inhibited melanoma growth and invasion, while those with a null Notch1 promoted melanoma invasion. These findings identify the Notch1 pathway as a molecular determinant that controls the regulatory role of CAF in melanoma skin growth and invasion, unveiling Notch1 signaling as a potential therapeutic target for melanoma and potentially other solid tumors.


Subject(s)
Fibroblasts/pathology , Melanoma/pathology , Receptor, Notch1/metabolism , Signal Transduction , Skin Neoplasms/pathology , Animals , Cell Proliferation , Fibroblasts/metabolism , Gene Deletion , Melanoma/genetics , Melanoma/metabolism , Mice , Neoplasm Invasiveness/genetics , Neoplasm Invasiveness/pathology , Receptor, Notch1/genetics , Skin Neoplasms/genetics , Skin Neoplasms/metabolism , Melanoma, Cutaneous Malignant
4.
Int J Clin Lab Res ; 30(1): 17-9, 2000.
Article in English | MEDLINE | ID: mdl-10984127

ABSTRACT

The production and action of primary proinflammatory cytokines are strictly controlled by a series of circuits to avoid damage that they can cause if produced in excess. Interleukin-10 and interleukin-1 receptor antagonist contribute to the control of the magnitude of the inflammatory responses in vivo. Benzydamine, a non-steroidal anti-inflammatory drug that has been shown to have suppressive activity for the proinflammatory cytokines, tumor necrosis factor-alpha and interleukin-1beta, was investigated for its effects on interleukin-10 and interleukin-1ra production. The drug did not modify the production of interleukin-10 and interleukin-1ra by peripheral blood mononuclear cells stimulated with lipopolysaccharide, under conditions where tumor necrosis factor-alpha and interleukin-1beta were decreased. The antiinflammatory capacity of benzydamine might thus result from its ability to reduce the production of proinflammatory cytokines, without affecting antiinflammatory factors.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Benzydamine/pharmacology , Chemokine CCL2/biosynthesis , Gene Expression Regulation/drug effects , Interleukin-10/biosynthesis , Interleukin-1/biosynthesis , Leukocytes, Mononuclear/drug effects , Sialoglycoproteins/biosynthesis , Tumor Necrosis Factor-alpha/biosynthesis , Cells, Cultured/drug effects , Chemokine CCL2/genetics , Humans , Inflammation , Interleukin 1 Receptor Antagonist Protein , Interleukin-1/genetics , Interleukin-10/genetics , Leukocytes, Mononuclear/metabolism , Lipopolysaccharides/pharmacology , Sialoglycoproteins/genetics , Tumor Necrosis Factor-alpha/genetics
5.
Lab Invest ; 80(7): 1095-100, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10908155

ABSTRACT

The beneficial effects of statins on the reduction of cardiovascular events has been partly attributed to their anti-inflammatory properties. In the complex of the different pathogenetic events leading to atherosclerosis, recent data suggest a central role of monocyte chemotactic protein-1 (MCP-1), because mice knock-out for MCP-1 or its receptor CC-chemokine receptor 2 were considerably resistant to plaque formation. In this study we investigated the effect of different statins on in vitro and in vivo production of MCP-1. Lovastatin and simvastatin caused a dose-dependent inhibition of MCP-1 production in peripheral blood mononuclear cells exposed to lipopolysaccharide or inactivated Streptococcus hemoliticus and in human endothelial cells exposed to interleukin-1beta. The addition of mevalonate overrode the inhibitory effect of statins indicating that mevalonate-derived products are important for chemokine production. The in vivo anti-inflammatory effect of statins was investigated using the mouse air-pouch model of local inflammation. Lovastatin and pravastatin were orally administered to mice according to a treatment schedule that significantly inhibited the hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity without affecting total blood cholesterol. At the dose of 10 mg/kg, lovastatin and pravastatin reduced by approximately 50% the lipopolysaccharide-induced leukocytes recruitment and the exudate MCP-1 production. In conclusion, statins, by inhibiting mevalonate-derived products, reduced both in vitro and in vivo the production of chemokines involved in leukocyte migration, and this effect is unrelated to their cholesterol-lowering action.


Subject(s)
Chemokine CCL2/antagonists & inhibitors , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Lovastatin/pharmacology , Pravastatin/pharmacology , Simvastatin/pharmacology , Cells, Cultured , Chemokine CCL2/biosynthesis , Chemokine CCL2/blood , Chemokine CCL2/genetics , Dose-Response Relationship, Drug , Humans , Leukocytes/physiology , Mevalonic Acid/antagonists & inhibitors , Monocytes/metabolism , RNA, Messenger/blood
6.
J Leukoc Biol ; 66(3): 489-94, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10496320

ABSTRACT

Upon exposure to immune or inflammatory stimuli, dendritic cells (DC) migrate from peripheral tissues to lymphoid organs, where they present antigen. The molecular basis for the peculiar trafficking properties of DC is largely unknown. In this study, mouse DC were generated from CD34+ bone marrow precursors and cultured with granulocyte-macrophage-CSF and Flt3 ligand for 9 days. Chemokines active on immature DC include MIP1alpha, RANTES, MIP1beta, MCP-1, MCP-3, and the constitutively expressed SDF1, MDC, and ELC. TNF-alpha-induced DC maturation caused reduction of migration to inducible chemokines (MIP1alpha, RANTES, MIP1beta, MCP-1, and MCP-3) and increased migration to SDF1, MDC, and ELC. Similar results were obtained by CD40 ligation or culture in the presence of bacterial lipopolysaccharide. TNF-alpha down-regulated CC chemokine receptor (CCR)1, CCR2, and CCR5 and up-regulated CCR7 mRNA levels, in agreement with functional data. This study shows that selective responsiveness of mature and immature DC to inducible vs. constitutively produced chemokines can contribute to the regulated trafficking of DC.


Subject(s)
Chemokines/pharmacology , Chemotaxis/drug effects , Cytokines , Dendritic Cells/drug effects , Animals , CD40 Ligand , Chemokine CCL19 , Chemokine CCL2/pharmacology , Chemokine CCL22 , Chemokine CCL4 , Chemokine CCL5/pharmacology , Chemokine CCL7 , Chemokine CXCL12 , Chemokines, CC/pharmacology , Chemokines, CXC/pharmacology , Down-Regulation/drug effects , Gene Expression Regulation/drug effects , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Hematopoietic Stem Cells/drug effects , Macrophage Inflammatory Proteins/pharmacology , Membrane Glycoproteins/pharmacology , Membrane Proteins/pharmacology , Mice , Mice, Inbred DBA , Monocyte Chemoattractant Proteins/pharmacology , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Receptors, CCR1 , Receptors, CCR2 , Receptors, CCR5/biosynthesis , Receptors, CCR5/genetics , Receptors, CCR7 , Receptors, Chemokine/biosynthesis , Receptors, Chemokine/genetics , Receptors, Cytokine/biosynthesis , Receptors, Cytokine/genetics , Tumor Necrosis Factor-alpha/pharmacology , Up-Regulation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...